LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.031623
6.94 771.67 1085 1045 1.0382 1.1787
MN20160304_L01
L22
MCF 10A-H2B-mCherry Trametinib
0.031623
9.16 771.67 1010 1138 0.8871 0.6156
MN20160304_L01
D07
MCF 10A-H2B-mCherry Trametinib
0.031623
9.16 771.67 1194 1138 1.0487 1.1771
MN20160304_L01
L22
MCF 10A-H2B-mCherry Trametinib
0.031623
11.56 771.67 1099 1280 0.8582 0.6223
MN20160304_L01
D07
MCF 10A-H2B-mCherry Trametinib
0.031623
11.56 771.67 1315 1280 1.0268 1.0738
MN20160304_L01
L22
MCF 10A-H2B-mCherry Trametinib
0.031623
13.78 771.67 1220 1459 0.8358 0.6455
MN20160304_L01
D07
MCF 10A-H2B-mCherry Trametinib
0.031623
13.78 771.67 1465 1459 1.0036 1.0078
MN20160304_L01
L22
MCF 10A-H2B-mCherry Trametinib
0.031623
16.00 771.67 1294 1585 0.8162 0.6448
MN20160304_L01
D07
MCF 10A-H2B-mCherry Trametinib
0.031623
16.00 771.67 1532 1585 0.9663 0.9350
MN20160304_L01
L22
MCF 10A-H2B-mCherry Trametinib
0.031623
18.22 771.67 1331 1741 0.7643 0.5909
MN20160304_L01
D07
MCF 10A-H2B-mCherry Trametinib
0.031623
18.22 771.67 1573 1741 0.9033 0.8341
MN20160304_L01
L22
MCF 10A-H2B-mCherry Trametinib
0.031623
20.44 771.67 1336 1910 0.6992 0.5213
MN20160304_L01
D07
MCF 10A-H2B-mCherry Trametinib
0.031623
20.44 771.67 1564 1910 0.8185 0.7161
MN20160304_L01
L22
MCF 10A-H2B-mCherry Trametinib
0.031623
22.66 771.67 1332 2141 0.6220 0.4488
MN20160304_L01
D07
MCF 10A-H2B-mCherry Trametinib
0.031623
22.66 771.67 1574 2141 0.7350 0.6227
MN20160304_L01
L22
MCF 10A-H2B-mCherry Trametinib
0.031623
24.89 771.67 1319 2397 0.5501 0.3878
MN20160304_L01
D07
MCF 10A-H2B-mCherry Trametinib
0.031623
24.89 771.67 1569 2397 0.6544 0.5432
MN20160304_L01
L22
MCF 10A-H2B-mCherry Trametinib
0.031623
27.11 771.67 1349 2675 0.5043 0.3654
MN20160304_L01
D07
MCF 10A-H2B-mCherry Trametinib
0.031623
27.11 771.67 1555 2675 0.5813 0.4780
MN20160304_L01
L22
MCF 10A-H2B-mCherry Trametinib
0.031623
29.33 771.67 1328 2939 0.4518 0.3249
MN20160304_L01
D07
MCF 10A-H2B-mCherry Trametinib
0.031623
29.33 771.67 1524 2939 0.5185 0.4229
MN20160304_L01
L22
MCF 10A-H2B-mCherry Trametinib
0.031623
31.55 771.67 1323 3196 0.4139 0.3007
MN20160304_L01
D07
MCF 10A-H2B-mCherry Trametinib
0.031623
31.55 771.67 1574 3196 0.4924 0.4157
MN20160304_L01
L22
MCF 10A-H2B-mCherry Trametinib
0.031623
33.78 771.67 1295 3499 0.3700 0.2679
MN20160304_L01
D07
MCF 10A-H2B-mCherry Trametinib
0.031623
33.78 771.67 1529 3499 0.4369 0.3682
MN20160304_L01
L22